Victorian opposition plan to sell state venture fund for healthcare draws criticism

The proposal, reported by Startup Daily, would liquidate a state venture capital fund valued at about $2 billion, redirecting the capital towards the opposition's healthcare package aimed at reducing surgery waiting lists.

In an opinion piece for Startup Daily, Kate Gaffney, a farmer and sessional university academic, argues the plan conflates two policy challenges: improving healthcare today, and building the investment architecture needed to grow the economy that funds it tomorrow, including medical innovations that can strengthen the system.

"Solving the first by dismantling the second would trade long-term capability for short-term budget relief," she writes.

Gaffney acknowledges the proposal's political appeal. "To a voter stuck on a multi-year waiting list for surgery, it sounds like common sense: close down a $2 billion venture capital fund that most Victorians have never heard of and put that money towards reducing the surgery waiting list."

She says long waiting lists are not abstract or new, drawing on her own family's experience, and argues the Hollywood caricature of venture capital bears little resemblance to Victoria's innovation economy, where founders work in warehouses, laboratories and small manufacturing facilities to turn research into products that improve people's lives.

The piece lands weeks before Victorians go to the polls, placing the future of the state's direct role in venture investing on the election agenda.

Analysis

Why This Matters

The plan would put a $2 billion government-owned venture portfolio on the market, ending the state's direct role in backing early-stage companies and redirecting the capital to hospital funding.
It frames healthcare spending and innovation investment as competing priorities in an election campaign, a trade-off the author argues is false.
The outcome matters to Victorian startups and medical technology companies that depend on patient capital from the state.

Background

Innovation Victoria is the state government's innovation agency, created to support the startup ecosystem and partner with private venture investors. The Coalition opposition has proposed winding up its investment arm and selling the early-stage portfolio to help finance a $1.27 billion healthcare package. The Startup Daily commentary argues the sale would deliver short-term budget relief while eroding the long-term capability that funds the economy, and the healthcare system, of the future. The author says her own family has experienced hospital waiting lists and that the frustration voters feel is genuine.

Key Perspectives

The Victorian Coalition: Treats the fund as a liquid asset and has proposed selling it to help pay for a healthcare package aimed at reducing surgery waiting lists. Innovation economy advocates: Argue venture capital is patient capital that builds companies, jobs and medical technologies, and that dismantling the fund is a false economy. Voters on waiting lists: The author acknowledges the proposal sounds like common sense to people who have waited years for surgery, even as she argues the trade-off is the wrong one.

What to Watch

Whether the Coalition formalises the sell-down in its election platform and how the portfolio is valued.
How the state government defends Innovation Victoria and the fund's track record.
The election result, which will determine whether the portfolio is sold, wound up or retained.

Analysis

Why This Matters

Background

Key Perspectives

What to Watch

Sources